Form 424B3 - Prospectus [Rule 424(b)(3)]
31 August 2024 - 6:44AM
Edgar (US Regulatory)
August 30, 2024 |
Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(3) |
JPMorgan Chase Financial Company LLC
Structured Investments
Auto Callable Contingent Interest Notes Linked to the
Least Performing of the S&P 500® Index, the Nasdaq-100 Index® and the Russell 2000® Index
due August 13, 2026
Fully and Unconditionally Guaranteed by JPMorgan Chase
& Co.
Notwithstanding anything to the contrary set forth in
the pricing supplement dated August 9, 2024, related to the notes referred to above (the “pricing supplement”), the Contingent
Interest Payments and the Contingent Interest Rate are as set forth below:
Contingent Interest Payments: If
the notes have not been automatically called and the closing level of each Index on any Review Date is greater than or equal to its Interest
Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount note a Contingent Interest Payment
equal to $25.625 (equivalent to a Contingent Interest Rate of 10.25% per annum, payable at a rate of 2.5625% per quarter).
If the closing level of any Index on any Review Date is less than
its Interest Barrier, no Contingent Interest Payment will be made with respect to that Review Date.
Contingent Interest Rate: 10.25%
per annum, payable at a rate of 2.5625% per quarter
CUSIP: 48135P7A3
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk
Factors” beginning on page PS-11 of the accompanying product supplement and “Selected Risk Considerations” beginning
on page PS-5 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this amendment,
the pricing supplement or the accompanying product supplement, prospectus supplement, prospectus and prospectus addendum. Any representation
to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement
and the related product supplement, prospectus supplement and prospectus and prospectus addendum, each of which can be accessed via the
hyperlinks below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.
· Pricing supplement dated August 9, 2024:
http://www.sec.gov/Archives/edgar/data/19617/000121390024068180/ea179193_424b2.htm
· Product supplement no. 4-I dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf
· Prospectus supplement and prospectus, each dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf
· Prospectus addendum dated June 3, 2024:
http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm
Amendment no. 1 to pricing supplement dated August 9, 2024
to product supplement no. 4-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus
addendum dated June 3, 2024
JP Morgan Alerian MLP (AMEX:AMJ)
Historical Stock Chart
From Oct 2024 to Nov 2024
JP Morgan Alerian MLP (AMEX:AMJ)
Historical Stock Chart
From Nov 2023 to Nov 2024